Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer.

被引：0
|
作者：
de Lange, SM
van Groeningen, CJ
Giaccone, G
Pinedo, HM
Meijer, OWM
Langendijk, JA
Slotman, BJ
机构：
[1] Vrije Univ Amsterdam, Univ Hosp, Dept Med Oncol, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Univ Hosp, Dept Radiotherapy, Amsterdam, Netherlands
来源：
CLINICAL CANCER RESEARCH | 2000年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
371
引用
收藏
页码：4540S / 4541S
页数：2
相关论文
共 50 条
  • [41] A single institutional experience of carbon-ion radiotherapy for locally advanced pancreatic cancer.
    Shinoto, Makoto
    Shioyama, Yoshiyuki
    Suefuji, Hiroaki
    Toyama, Shinto
    Matsumoto, Keiji
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [42] Phase I study of veliparib with gemcitabine and radiation therapy in patients with borderline resectable and locally advanced unresectable pancreatic cancer.
    Tuli, Richard
    Nissen, Nicholas N.
    Annamalai, Alagappan
    Hoffman, David M. J.
    Bryant, Miranda
    Tighiouart, Mourad
    Rogatko, Andre
    Rokhsar, Sepehr
    Scher, Kevin S.
    Jamil, Laith
    Lo, Simon
    Hendifar, Andrew Eugene
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [43] Multimodality treatment of 132 consecutive patients with locally advanced pancreatic cancer.
    Vogel, Jantien A.
    de Rooijt, Thijs
    van Lienden, Krijn P.
    Wilmink, Johanna W.
    van Laarhoven, Hanneke W.
    van Hooft, Jeanin E.
    van Delden, Otto M.
    Dijkgraaf, Marcel G.
    Martin, Robert C. G.
    Busch, Olivier R. C.
    Besselink, Marc G.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] Stereotactic radiotherapy after chemotherapy in patients with locally advanced pancreatic cancer
    LE ROY, C.
    Barbe, R.
    Sun, R.
    Burtin, P.
    Gelli, M.
    Deutsch, E.
    Durand-Labrunie, J.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1089 - S1089
  • [45] Local effect and gastrointestinal toxicity for carbon-ion radiotherapy in patients with unresectable locally advanced pancreatic cancer.
    Shinoto, Makoto
    Shioyama, Yoshiyuki
    Suefuji, Hiroaki
    Matsunobu, Akira
    Toyama, Shingo
    Kudo, Sho
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [46] Phase II study of gemcitabine, capecitabine and cisplatin in patients with advanced pancreatic cancer.
    Chang, HM
    Kim, TW
    Ahn, JH
    Ryu, MH
    Lee, JS
    Kim, WK
    Kang, YK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 368S - 368S
  • [47] Low dose gemcitabine plus concurrent radiotherapy with or without amifostine in locally advanced head and neck cancer.
    Jaremtchuk, AV
    Zarba, JJ
    Keropian, M
    Jazey, PG
    Castagnino, R
    CLINICAL CANCER RESEARCH, 2000, 6 : 4540S - 4540S
  • [48] Gemcitabine and oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer
    All, M.
    Carillio, G.
    Mazzola, A.
    Bagnato, S.
    Di Leo, M. G.
    Fallica, G.
    Anna, Aiello R.
    Chiarenza, M.
    Caruso, M.
    ANNALS OF ONCOLOGY, 2006, 17 : XI52 - XI52
  • [49] Prediction of gemcitabine resistance in patients with pancreatic cancer.
    Nakahira, S.
    Nakamori, S.
    Tsujie, M.
    Okami, J.
    Takemasa, I.
    Takeda, Y.
    Nagano, H.
    Dono, K.
    Sakon, M.
    Monden, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 209S - 209S
  • [50] Single institution experience of chemoradiation with gemcitabine versus capecitabine in borderline resectable and locally advanced pancreatic cancer.
    Kotowski, Adam S.
    Yarlagadda, Naveen
    May, Kilian Salerno
    Warren, Graham Walter
    Kuvshinoff, Boris W.
    Wilkinson, Neal W.
    Tan, Wei
    Iyer, Renuka V.
    Ma, Wen Wee
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345